• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Silence Therapeutics Plc - American Depository Share (NQ:SLN)

8.680 -0.670 (-7.17%)
Delayed Quote Updated: 4:00 PM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,131,128
Open 9.100
Bid (Size) 8.660 (2,600)
Ask (Size) 8.680 (500)
Prev. Close 9.350
Today's Range 8.660 - 9.220
52wk Range 4.190 - 17.58
Shares Outstanding 107,808,471
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Silence Therapeutics to Participate in Three September Investor Conferences
September 02, 2026
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs
August 14, 2026
From Silence Therapeutics plc
Via Business Wire

Performance

52-Week Range 50.6% below 52-week high
8.680
4.1952W Low 17.5852W High
1 Week 16.5% below 1-week high
8.711W Low 10.391W High

Silence Therapeutics Plc - American Depository Share (SLN) traded between $4.19 and $17.58 over the past 52 weeks and last traded at $8.68, 50.6% below its 52-week high. Over the past week it ranged between $8.71 and $10.39.

Past 12 Months
-12.0%
-30.3%
-20.5%
+14.2%
+41.1%
+36.1%
1W -$1.18
1M -$3.78
3M -$2.24
6M +$1.08
YTD +$2.53
1Y +$2.30

SLN was +36.1% over the past year, +14.2% over six months, +41.1% year to date, -12.0% in the last week.

12 Months vs Market
SLN
+36.1%
DIA
+12.2%
SPY
+14.7%
QQQ
+17.9%
IWM
+8.0%

Over the past 12 months SLN returned +36.1% versus DIA (Dow) +12.2%, SPY (S&P 500) +14.7%, QQQ (Nasdaq 100) +17.9% and IWM (Russell 2000) +8.0%.

Volume & Liquidity 0.95× 3-mo avg
Today 1,131,128 3-mo avg 1.2M
1W
1.3M
1M
1.1M
3M
1.2M
6M
801.8K
YTD
627.2K
1Y
548.7K

SLN most recently traded 1,131,128 shares against a 3-month average daily volume of 1.2M.

More News

Read More
News headline image
Silence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering
August 11, 2026
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence Therapeutics’ Divesiran Hits Phase II Goal, Sets Up Phase III PV Trial ↗
August 11, 2026
Via MarketBeat
News headline image
Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares
August 10, 2026
From Silence Therapeutics plc
Via Business Wire
There are notable gap-ups and gap-downs in today's session. ↗
August 10, 2026
Via Chartmill
Wondering what's happening in today's pre-market session? ↗
August 10, 2026
Via Chartmill
News headline image
Silence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile
August 10, 2026
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence Therapeutics Reports Second Quarter 2026 Financial and Business Results
August 10, 2026
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence Therapeutics to Host Conference Call and Webcast to Discuss Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera
August 09, 2026
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera
June 11, 2026
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence Therapeutics to Participate in Jefferies Global Healthcare Conference
May 27, 2026
From Silence Therapeutics plc
Via Business Wire
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
May 12, 2026
Via Chartmill
News headline image
Silence Therapeutics to Participate in H.C. Wainwright BioConnect Investor Conference
May 12, 2026
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence Therapeutics Highlights Recent Business Achievements and Reports First Quarter 2026 Financial Results
May 07, 2026
From Silence Therapeutics plc
Via Business Wire
Keep an eye on the top gainers and losers in Wednesday's session. ↗
May 06, 2026
Via Chartmill
Traders are paying attention to the gapping stocks in Wednesday's session. ↗
April 29, 2026
Via Chartmill
Top movers in Thursday's session ↗
April 23, 2026
Via Chartmill
Monday's session: gap up and gap down stocks ↗
April 06, 2026
Via Chartmill
Here are the top movers in Monday's session. ↗
March 30, 2026
Via Chartmill
Top stock movements in today's session. ↗
March 27, 2026
Via Chartmill
Keep an eye on the top gainers and losers in Friday's session. ↗
March 27, 2026
Via Chartmill
Which stocks are gapping on Friday? ↗
March 27, 2026
Via Chartmill
Top movers analysis one hour before the close of the markets on 2026-03-26: top gainers and losers in today's session. ↗
March 26, 2026
Via Chartmill
Here are the top movers in Thursday's session. ↗
March 26, 2026
Via Chartmill

Frequently Asked Questions

Is Silence Therapeutics Plc - American Depository Share publicly traded?
Yes, Silence Therapeutics Plc - American Depository Share is publicly traded.
What exchange does Silence Therapeutics Plc - American Depository Share trade on?
Silence Therapeutics Plc - American Depository Share trades on the Nasdaq Stock Market
What is the ticker symbol for Silence Therapeutics Plc - American Depository Share?
The ticker symbol for Silence Therapeutics Plc - American Depository Share is SLN on the Nasdaq Stock Market
What is the current price of Silence Therapeutics Plc - American Depository Share?
The current price of Silence Therapeutics Plc - American Depository Share is 8.680
When was Silence Therapeutics Plc - American Depository Share last traded?
The last trade of Silence Therapeutics Plc - American Depository Share was at 10/16/26 04:00 PM ET
What is the market capitalization of Silence Therapeutics Plc - American Depository Share?
The market capitalization of Silence Therapeutics Plc - American Depository Share is 935.78M
How many shares of Silence Therapeutics Plc - American Depository Share are outstanding?
Silence Therapeutics Plc - American Depository Share has 936M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap